';

QuantuMDx is dedicated to making transformative, quality diagnostic technologies accessible to everyone, so that diseases can be detected & treated earlier and transmission eradicated.

QuantuMDx Group is an ambitious life sciences tools and diagnostics developer. Headquartered in the United Kingdom, we have operations and global partnerships with healthcare providers in the United States, Asia, Australasia, Europe and Africa.

QuantuMDx is transforming molecular diagnostics with the development of leapfrog technologies for use under the tree and in clinics, pharmacies, hospitals and labs.

The company’s product range innovates each aspect of the DNA testing process, from extraction to amplification to detection.

QuantuMDx has received grants from the UK and EU governments, and partnered with FIND in 2014.
QuantuMDx was founded in March 2008
QuantuMDx has over 75 staff
QuantuMDx has received 10 awards
Investors
The company has raised funds through both grants and private investment.

QMDx_IP_Logos_144

SHARE THIS PAGE

Strong IP
QuantuMDx has exclusive licenses, a strong owned IP portfolio and utilises off-patent technologies. The patent portfolio comprises IP surrounding each of the component technologies and products in our range.
13
Patent Families
33
Granted Patents
7
Provisional Patents Pending
applications for its technologies
Subscribe to our e-newsletter and keep up to date with QuantuMDx

THE FUTURE OF DIAGNOSTICS

E-NEWSLETTER

Contact

Contact

Contact

  • MENU